With the goal of discovering genes that contribute to late-onset neurological and ocular disorders and also genes that extend the healthy life span in mammals, we are phenotyping mice carrying new mutations induced by the chemical N-ethyl-N-nitrosourea (ENU). The phenotyping plan includes basic behavioral, neurohistological, and vision testing in sibling cohorts of mice aged to 18 months, and then evaluation for markers of growth trajectory and stress response in these same cohorts aged up to 28 months. Statistical outliers are identified by comparison to test results of similar aged cohorts, and potential mutants are recovered for re-aging to confirm heritability of the phenotype.
Introduction
The Tennessee Mouse Genome Consortium (TMGC), a scientific and administrative association of public (The University of Tennessee, East Tennessee State University, University of Memphis) and private (Meharry Medical College, Vanderbilt University) universities, a clinical research institution (St. Jude Children's Research Hospital), and a national laboratory (Oak Ridge National Laboratory) was formed in 1998 for joint research projects utilizing statewide clinical, academic, and basic research expertise. Awarded a UO1 grant (UO1 MH61971) from the National Institute of Mental Health in 1999 for mutagenesis and phenotype-screening for disorders in behavior and the central nervous system, the TMGC effort includes an aging-colony core component designed to discover both lifespan-compromising and lifespan-extending single-gene recessive mutations. A genetics strategy was designed to produce enough genetically similar mice from each breeding pedigree to allow multi-site screening and sufficient statistical power for identification of outliers manifesting abnormalities in these variable and complex traits. The goal of the phenotyping protocols for all TMGC cores (general behavior, social behavior, drug related behavior, alcohol sensitivity, hearing, eye, neurohistology, epilepsy, and aging) is to perform primary screening tests that identify, and then validate as heritable, abnormal phenotypes resulting from the induction of new gene mutations.
We have learned many times throughout the genecloning years that biology is full of surprises, and that the set of functions associated with any gene throughout the life of the organism can be unpredictable. Because of this, the TMGC chose to take a phenotype-driven approach to this project, in which large numbers of mice carrying induced point mutations can be screened for phenotypes of interest without any prior knowledge of which genes or genetic pathways may determine the traits. The only induced mutations that count in this approach are the ones ascertained because they cause an abnormal phenotype. The downside to this approach is that after a phenotype of interest is discovered and confirmed, it remains to map and confirm the gene that has been altered to produce the phenotype. However, given our high-throughput methods for identifying ENU-induced single-basepair changes in the DNA of coding sequences of genes that may be likely candidates, our chances of associating gene with phenotype are reasonable. Phenotype-driven gene discovery can also be approached using mouse mapping strain sets, like recombinant inbred strains, that offer natural genetic variants (single-basepair changes or other polymorphisms) that confer phenotypic differences amenable to measurement. The power of the currently available mapping strains for associating gene with phenotype is severely limited by the numbers of strains available in mapping sets; this difficulty will be overcome with the generation of the Collaborative Cross, a complex-trait community effort to breed 1000 recombinant inbred strains from eight genetically diverse inbred strains (Vogel 2003; The Complex Trait Consortium 2004; de Haan and Williams 2005) .
The mutagen is N-ethyl-N-nitrosourea (ENU), a chemical that induces mostly point mutations in mouse spermatogonial stem cells. Each pedigree descends from one mutagenized male gamete, and the genotype of that gamete is tracked through the breeding scheme by following either a visible phenotypic marker or a set of DNA markers. Mice for screening are generated both at the Oak Ridge National Laboratory (ORNL) and at The University of Tennessee Health Sciences Center (UTHSC) in Memphis. In the case of ORNL, the mutagenized chromosome is brought to homozygosity in the third generation opposite a Bbalancer^chromosome with a large chromosomal inversion that includes both a dominant lethal mutation and a recessive mutation that confers a visually identifiable phenotype. Mice of the genotype that is homozygous for the mutagenized G 0 grandparental chromosome constitute the Btest class,^or the genotypic class that should manifest any abnormal recessive phenotypes caused by a new ENU-induced mutation in the region of the grandparental chromosome Bbalanced^by the chromosomal inversion. This third generation also includes mice that are heterozygous for the mutagenized grandparental chromosome and thus are carriers for any newly induced mutation that might be a developmental or genetic lethal. These G 3 heterozygous carriers would manifest new mutant phenotypes only if the new mutation were dominant (in which case the G 1 mice in the breeding strategy would also manifest the dominant phenotype). For the purposes of high throughput for primary screening by the TMGC, only the Btest-class^mice are assayed for abnormal phenotypes; phenotypic effects of new mutations in other genotypes are tested later during confirmation of heritability.
In the case of mice produced at UTHSC, the mutagenized males are consomic for a PWK or A/J chromosome introgressed into the C57BL/6J background. G 3 mice homozygous for new mutations in the PWK or A/J G 0 grandparental Btarget^chromo-some are identified by microsatellite genotyping, and constitute the Btest class^as above. For the aging core, four males and four females of the Btest classâ re group-housed at weaning to await behavioral screening at 18 months for age-onset neurological disorders and screening at 19Y24 months for factors (related to growth and stress response) thought to be predictive of longevity. All mice are weighed at least monthly beginning at weaning or earlier, and after the final screening are aged to 28 months or longer.
Three and a half years into this five-year project, we have aged 325 pedigrees to 18 months and 202 pedigrees to 28 months or more. We have screened the 18-month-old mice for abnormalities in general central nervous system function (locomotor activity, startle reflex, habituation to startle, and prepulse inhibition of the startle reflex, learning and memory as assessed by fear conditioning, nociception), neurohistology, and eye morphology. We have screened the 19-month or older mice for body weight, blood glucose, leptin, insulin, insulin-like growth factor, corticosterone, and ability to maintain body temperature in the cold. Many pedigrees remain to be screened for these age-related phenotypes, and we have identified putative mutants (Bputants^) for most screens. Pedigrees are being recovered for confirmation of heritability of the ascertained phenotype by breeding old males or by performing intracytoplas-mic sperm injection (ICSI) using sperm routinely frozen from young males from the pedigree.
Materials and methods
Mice. Mice for aging were generated using chromosomal inversions of two mouse chromosomes (Chr), 7 and 15 (ORNL) and consomics for Chr 14 and 19 (UTHSC). Table 1 shows the strains that were mutagenized and the mating partners, the dose of ENU, the markers followed (visually or by genotyping), and additional information about the genetic backgrounds. The strategy for Chr 15 and for the use of chromosomal inversions applicable to these experiments have been described (Rinchik 2000) .
For Chr 7, the mutagenized strain was the noninbred D7R75M stock (a/a; p 7R /p 7R ). The p 7R mutation is the visible marker (fur color) making a coat color that is intermediate between wild-type and p. The chromosome carrying the p x mutation is the one that also carries the new ENU mutations, so we can follow the location of the ENU mutations by following the p x marker. In addition, mice that are p x /p x in coat color are the test class; absence of this color class means that the new recessive mutation is an embryonic lethal.
The Chr-7 region corresponding to the Btarget region^for mutagenesis in this screen is predominantly of C3H origin, based on an SSLP survey of a number of p 7R /p 7R G 3 or greater mice (see below), although it could be of B6 origin in any one mouse in any one pedigree. Mice homozygous for p 7R are darker in color than are p 7R /p, or p 7R /In(7)p4Rl animals. The prenatally recessive-lethal ln(7)p4Rl inversion (Russell et al. 1995 ) was used as a dominantly marked, recessive-lethal Bbalancer^to follow mutagenized chromosomes so that the Btest class^homozygous for the mutagenized chromosome could be visually detected in G 3 . The proximal breakpoint of the inversion maps within the p gene itself, while the distal breakpoint maps some 20 cM distal, in the vicinity of pid, just proximal to Myo7a. The lethal In(7)p4Rl inversion was maintained by crosses of p 7R /In (7) For Chr 15. the mutagenized strain was C3H/Rl, and the balancer inversion, congenic on C3H/Rl, is called 4R250M and carries the dominant-lethal marker hairy ears (Eh). The ENU-treated G 0 males were mated to Eh/+ females, and the G 1 males or females (Eh ++/+ m +, where m indicates a newly induced mutation) were crossed to Eh ++/++ Crld, This latter stock, also congenic on C3H/Rl, segregates both the Eh inversion and Caraculoid (Crld ), a dominant Caracol-like mutation that does not re- A /Na/J and C57BL/6JYChr 19 PWK were mutagenized and mated to C57BL/6J females. This strategy has been described (Williams 1999) . G 1 offspring that maintained whole chromosomes 14 or 19 (from A/J or PWK) were selected using the microsatellite markers listed in Table 1 and intercrossed. Again, G 2 that maintained whole chromosomes 14 or 19 (from A/J) were selected using the microsatellite markers listed in Table 1 and intercrossed to form the G 3 test class.
Mutagenesis. Males were given a single or multiple weekly intraperitoneal injections of ENU, prepared as previously described Russell et al. (1979) at doses given in Table 1 . ENU was obtained from Sigma (St. Louis, MO). From Table 1 , the mice being screened that have reached at least 18 months in the aging colony at this writing are from experiments TNA, TNB, TNC, TND, TNP, CH14, and CH19. After fertility returned, the males were mated to experiment-appropriate females as outlined above.
Test-class animals in each pedigree were observed at weaning for obvious neuromuscular and/or behavioral phenotypes, size differences, and other visible phenotypes. Mutant phenotypes should be apparent only in the test-class; mutant phenotypes appearing in other genotypic classes of G 3 mice, but not in any of their parents, predict an unlinked recessive mutation. At ORNL, the test-class mice were weighed at two weeks postnatal as whole litters and at six weeks as individuals; each mouse at both ORNL and UTHSC is weighed at weaning, at eight weeks of age, and then monthly thereafter. The absence of test-class animals in 15 or more animals of any pedigree (one-third expected, P G 0.002), identified pedigrees in which homozygosity for that mutagenized chromosome segment is pre-or neonatally lethal due to mutations in essential developmental functions. Breeding stocks were established from any pedigrees with visible or lethal mutations; all mutations, including lethal or otherwise detrimental ones, were propagated from intercrossing the G 2 siblings heterozygous for the ENU mutation and the Bbalancer^i nversion. For each pedigree, two young males were sacrificed for cryopreservation of sperm, one young female underwent a microCT scan, and brain, liver, spleen, kidney, tail, ovary, and testis were archived by freezing.
For all pedigrees with an apparently normal test class, four males and four females were set aside in group housing at weaning, and aged to 18 months. Each mouse was weighed at weaning, at six weeks, and then monthly, and examined quarterly by an experienced technician for visible abnormalities, including a click-box test for hearing. At 18 months, two males and two females went through a general behavior-test regime, and one male and one female were sent to UTHSC for neurohistology (leaving six mice to age to 28 months or more). In recent months, these two aged mice from each pedigree also underwent eye examination prior to sacrifice for neurohistology. Detailed protocols for all tests and stains may be found at http://www.tnmouse.org, but briefly, each of the four mice from each pedigree was given a 20-min open-field activity test in a HamiltonYKinder chamber, concurrent assessments of acoustic startle, startle habituation, and prepulse inhibition of startle reflex in a HamiltonYKinder startle chamber, cued and contextual fear conditioning (electric shock to the foot pads), and a 52 -C hotplate test for nociception. For neurohistological examination, one mouse was taken for perfusion fixation 1 hour after an i.p. injection of bromo-deoxyuridine (BrdU) to label mitotically active cells and another for fresh taking of the brain which was weighed and frozen in isopentane cooled to j80 -C. These brains were then processed for a series of histological stains to highlight specific aspects of the neuropil including neurons, glia, transmitter-specific cell bodies and projections, and proliferatively active cells.
For the ocular examination, the anterior and posterior segments of the eyes of one mouse aged to 18 months from each pedigree were evaluated using a slitlamp biomicroscope and an indirect ophthalmoscope. Images were also taken of the posterior segment with a fundus camera. Eyes were then processed to assess for variations in ocular structure and to highlight specific retinal markers.
Recovery of potentially mutant pedigrees. When possible, putants are recovered via breeding of aged males to young wild-type females of appropriate genetic strains. For example, for putants on Chr 15, aged homozygous-mutant males are bred to C3H/Rl females to generate F 1 heterozygotes, which are then intercrossed to generate an F 2 population for aging, phenotyping, and confirmation of heritability. Twenty-five percent of aged F 2 s should manifest a recessive mutant phenotype that is heritable.
If the aged males do not breed, the pedigree is recovered via intracytoplasmic sperm injection (ICSI) using sperm cryopreserved from a young homozygous-mutant male of the pedigree. Donor eggs are derived by superovulation of females of the appropriate genetic background to generate F 1 progeny.
The collection and cryopreservation of spermatozoa, superovulation of female mice, collection of oocytes, ICSI, preimplantation culture conditions, and transfer of two-cell stage embryos into foster mothers were performed essentially as described (Kimura and Yanagimachi 1999; Kawase et al. 2001; Szczygiel et al. 2002 and references therein) . Briefly, sperm were obtained from the epididymides and vas deferentia of each mouse in 1 ml of cryoprotectant (18% raffinose, 3% nonfat dried milk in distilled water) and distributed into straws in aliquots of 100 ml. The straws were sealed, suspended in the vapor phase of liquid nitrogen in a styrofoam cooler for 10 min prior to immersion and storage in liquid nitrogen. Mice were induced to superovulate with intraperitoneal injections of PMSG (5 IU), followed 48 h later with HCG (5 IU). Oviducts were removed 12Y15 hr after the injection of HCG, and the cumulus cell-oocyte masses were released from the ampullae into 0.1% hyaluronidase to obtain oocytes free of cumulus cells for ICSI. Prior to ICSI, one straw containing cryopreserved sperm was quickly thawed in a 37 -C water bath. The sperm was expelled from the straw, thoroughly washed in saline solution to remove cryoprotectant, centrifuged, resuspended in 300 ml of saline and distributed into aliquots of 15 ml. One aliquot was used for ICSI and the remaining aliquots were refrozen in liquid nitrogen for subsequent days of ICSI. The sperm aliquot used for ICSI was placed in an equal amount of M2 media containing 16% polyvinyl pyrrolidone. ICSI was performed with a Prime Tech piezoelectric microinjection system (PMM-150FU), Eppendorf NK-2 micromanipulators, and a Nikon TMD microscope. Single sperm heads were injected into each oocyte. Fertilized eggs were cultured overnight in KSOM for the development of two-cell stage embryos, which were transferred into the oviducts of pseudopregnant ICR recipients. All experiments involving mice in this study were conducted under approved Institutional Animal Care and Use Committee protocols.
Screens being performed in the aging colony for stress and growth parameters Body weight. Body weights are taken at two weeks postnatal (entire litter), at weaning, at six weeks of age, at eight weeks of age, and then monthly thereafter to 28 months of age.
Cold challenge. Cold challenge to the ability to maintain core temperature is used to screen for energy-balance mutations and for stress resistance. For the cold-room challenge, mice are placed at 4 -C, in individual cages, and the rectal temperature of each mouse is taken with a rapid-read digital thermometer at 30-min intervals for up to 2 h. Normal mice maintain rectal temperature efficiently for the entire 2 h at 4 -C, whereas mice with energybalance defects will lose, and not be able to regain, a few degrees (Dr Streamson Chua, Columbia University, personal communication).
Measurement of IGF-1, corticosterone, insulin, leptin, and glucose. Mice that have been through the cold challenge are tested for these hormones. Mice are bled no sooner than one week after the cold challenge. Blood is drawn by nicking the large vein at the base of the tail of a lightly restrained and warmed mouse, and collecting drops of whole blood in microtainer tubes. The samples are centrifuged and serum is collected. The serum is aliquoted that same day and kept at j80 -C until analysis. Collection is done late in the afternoon from unfasted mice.
(a) Glucose (mg/dl): A drop of whole blood is analyzed using a One Touch Profile glucometer. Moustaid-Moussa's laboratory using 1Y5 ml of serum, using the Mouse Leptin ELISA kit obtained from Crystal Chem Inc. The same kit is used by the Jackson Laboratory for their mutagenesis screens.
Screens being performed in the aging colony for neurohistological abnormalities
Two mice from each pedigree are processed for examination using neurohistological stains. One mouse is decapitated and the brain and eyes weighed. The brain tissue is then dipped into room temperature isopentane (2-methylbutane) and the brains are cut midsagittally, placed on the cut surface, and quickfrozen in precooled isopentane (placed on dry ice for at least 30 min). Immediately after brain freezing the whole eyes are removed and frozen. Care is taken to minimize the time between decapitation and freezing (usually around 2.4Y3.2 min) The tissues are then placed in 2.0-ml cryo-vials on dry ice for 15 min, then stored at j80 -C. One half of each brain and one whole eye are mounted together (side by side, in the sagittal plane) using refrigerated TBS Tissue Freezing Medium on a room temperature cryostat chuck placed on dry ice. The chuck containing the mounted tissue is then allowed to equilibrate in the cryostat at j18 -C for 20 min and the tissue then cut into 20-mm sections and stored at j80 -C. until ready for staining. A series of 10 stains is carried out on the fresh frozen material:
1. Cell bodies and cytoarchitectonics are demonstrated using Cresyl violet (0.03%). 2. Astroglia are highlighted using antiglial fibrillary acidic protein (GFAP) immunocytochemistry (Immunon 460740, raised in rabbit). 3. The energy state and mitochondrial activity are highlighted using cytochrome oxidase histochemistry (tissue is stained using a filtered solution of 24 mg Cytochrome C (Sigma C-2506), Neurons are selectively highlighted using immunocytochemistry for anti-NeuN (Chemicon MAB377, raised in mouse; used at 1:1000). 8. Neuropathological alterations associated with the ubiquitination of proteins are examined using anti-ubiquitin immunostaining to highlight neuronal pathology. 9. Noradrenerigic and dopaminergic neurons and fibers are stained using anti tyrosine hydroxylase immunocytochemistry. 10. The mossy fiber projection from the dentate gyrus to the hippocampus is highlighted with the Timm's stain for heavy metals. Other terminal fields are also highlighted with this stain.
All slides are then dehydrated, differentiated, and coverslips are applied with Permount.
The second mouse is administered BrdU (Sigma, 0.1 ml/30 g body weight or 50 mg/kg) and sacrificed one hour later using perfusion fixation with 1:3 acetic acid/95% ethanol. The brains and eyes are removed and embedded into paraffin and sectioned at 8-mm thickness. Tissue is mounted on slides and typically stained for Cresyl violet, anti-GFAP, and anti-BrdU (Becton-Dickinson 347580, raised in mouse; used at 1:25) to test the reproducibility of results in the fresh frozen material for cells, glia, and cell proliferation. A fourth set of sections are stained for anti-Calbindin immunocytochemistry. Three stains are performed on sections from the perfusion-fixed brain using a pretreatment protocol consisting of 10 min in a 0.04% Pepsin (Sigma P-6887) in 1 N HCl solution, followed by rinses in 2Â SSC at 80 -C for 5 min, 70% ETOH at 60 -C for 2 min, 0.1 M PBS at room temperature for 3 min, and in 0.1 M PBS + 1% H 2 O 2 for 3 min. Slides are then immunocytochemically stained with anti-BrdU (Becton-Dickinson 347580, raised in mouse; used at 1:25), counterstained with 0.03% Cresyl violet for 20 min.
Screens being performed in the aging colony for eye abnormalities
To evaluate the ocular phenotype of each 18-monthold mouse (one mouse per pedigree), we utilized our protocols as previously described (Semenova et al. 2003; Martin et al. 2004) . Briefly, the anterior segment of the eye (i.e., cornea and lens) was examined using a slit lamp biomicroscope (Carl Zeiss, Germany). Images of these structures were recorded with a Canon GL1 digital video camera (Canon USA, Inc., Lake Success, NY) via a video adapter (Transamerican Technology International, San Ramon, CA). Pupils of mice lightly anesthetized with an intraperitoneal injection of Avertin were dilated with Cyclomydril (Alcon Pharmaceuticals, Fort Worth, TX). The fundus was examined by indirect ophthalmoscopy and photographs were taken with a Kowa Genesis small animal fundus camera (Genesis; Kowa, Torrance, CA) with the assistance of a 90-D condensing lens (Volk Optical, Mentor, OH) as described previously.
Paraffin sections of both eyes from each mouse were stained with Hemotoxylin and eosin using standard protocols. Additional slides were immunostained using antiglial fibrillary acidic protein (GFAP) antibodies (Thermo Electron Corporation 460740 at 6 drops per 1000 ml) and anti-calbindin D-28K (Chemicon AB1778 at 1:250 dilution). Immunoreaction products were visualized using a Vectorstain kit (Vector Laboratories, Inc., Burlingame, CA). Slides were examined on a Nikon Eclipse E800 microscope equipped with Sensys Color Camera (Photometrics, Tucson, AZ) and images were collected using MetaMorph Imaging System software (Universal Imaging, West Chester, PA).
Data analysis
Data from each of these tests are entered into Mutrack, the TMGC database at http://www.tnmouse.org, and Mutrack performs statistical analyses to identify outlier pedigrees for each screen. If the pedigree mean is 91.65 SD from the population mean (with 25% trimming and at least 10 pedigrees tested), and the pattern of the data points for each mouse relative to the mean is meaningful (see plots below), a pedigree is declared to be a Bputant^(putative mutant). BPutancyĉ ues retesting, which for the aging pedigrees means retest of already-tested mice and testing of any remaining aging mice. If retest results confirm the outlier status of the pedigree, that pedigree becomes a Bcutant^(confirmed putant). An aging pedigree can become a mutant (heritability confirmed) only when the pedigree is recovered from breeding old males or from intracytoplasmic sperm injection using frozen sperm and re-aged for testing.
Data Table) and growth/stress screens on aging mice (BPhysiologyû nder both Weekly Update and Test Table) are updated each week.
Results: potential mutants for behavior, neurohistology, eye
The pedigrees in Table 2 , potentially mutant for behavior tests performed at 18 months of age, were normal on the given test as young mice, suggesting an age-onset abnormality.
Neurohistology
Aged brains from 97 eighteen-month-old pedigrees have thus far been examined. All sections are uniformly processed with the same concentration of antibody, fixation protocol, thickness of tissue, and these findings are very reproducible in all of the aged pedigrees we have examined compared to all of the young examined. Thus, we conclude that the differences seen with each stain are caused by age-associated neuroanatomical changes, and that we will be able to detect age-associated abnormalities against this background of normal changes.
However, since we sample only 2 brains from each of these lines (so that they may age for another 10 months), these pedigrees cannot be unequivocally assigned as Bnormal^or Bmutant^. The idea is that any strikingly mutant lines will be designated for reexamination after recovery and re-aging. To date, we have identified 14 putative mutant lines with none having a phenotype that would, by itself, command the effort to recreate and age the line. Interestingly, however, one pedigree that may be an outlier for brain weight (n = only 2), 253TNB, is also an outlier for body temperature (see below in Figure 2 ) in the extra-ager screen. It will be interesting, however, to see how all of these putants look in the remaining cohort of their pedigree at 28 months. What we have identified is a set of neuroanatomical abnormalities that are associated with the aged brain. These include a dramatically decreased number of proliferating cells (indicated by arrows in Figure 1 ) in the rostral migratory stream (RMS) and dentate gyrus as seen with anti-BrdU immunocytochemistry (arrows in BrdU) panel. Likewise, there are reduced numbers of anti-histone H3 positive cells in these areas; H3 and BrdU staining suggest a normal, age-related reduction in the amount of cell proliferation in the these areas. There also is an increase in ectopically placed histone H3-positive cells in regions that are not identified as normally proliferative including the striatum and various areas of cortex (data not shown). This may represent cells with DNA damage and repair. An increase in GFAP immunoreactivity is also a hallmark of the aged brain, and this is particularly obvious in the thalamus. Finally, there is a variable but obvious drop out of Calbindin-positive Purkinje cells in the aged cerebellum. These attributes of the 18-month-old brain, compared to the 10-week-old brain, are illustrated in the Figure 1 .
Ocular phenotypes
The ocular phenotypes of 35 eighteen-month-old pedigrees have been evaluated. Upon immunohistochemical evaluation, all pedigrees had an increase in GFAP immunoreactivity, similar to the increase noted in the brains of aged mice. Of the 35 lines examined (one mouse per line), five pedigrees were part of the TNA/TNB/TNC projects and were therefore homozygous for mutations in retinal degeneration (rd, Pdeb Y the rd mutation is carried by the inbred strain C3H, and so is segregating in the background as a preexisting mutation in some of the mice being screened). These mice had severely degenerated retinas that were obvious on both the ophthalmic and histological exams. Ten pedigrees had a cataract that precluded the evaluation of the fundus; the cataracts were not graded, and were not considered further as abnormalities resulting from new mutations. The corneas of two independent pedigrees were opaque to varying degrees, thus also limiting our visibility of the fundus in the intact eye. In all of these lines, our evaluation of the retina was limited to the histological and immunohistochemical evaluation of the eye. In nine TND and TNP pedigrees, the fundus was slightly pale at a subretinal level, which is suggestive of loss of pigmentation of the retinal pigmented epithelium (RPE) and/or choroid. This finding was not present in all TND and TNP pedigrees; four other mice had normal pigmentation levels of the fundus. The 44TNJ pedigree, a pedigree that is a wellcharacterized mutant line in 8-to 10-week-old mice, was the most severely affected pedigree in the aged mice that we examined. In this line, an examination of the fundus was precluded due to a cloudy cornea. Histological evaluation revealed that the outer nuclear layer containing photoreceptor nuclei was thinner, suggestive of photoreceptor cell death. The inner and outer segments of the remaining photoreceptors were shortened compared to other aged mice. Moreover, the continuity of the outer plexiform layer was disrupted, as was the calbindin-positive staining of the horizontal cell processes that should be located in this plexiform layer. The cell bodies of the horizontal cells also had significantly lighter calbindin-positive staining than those of other aged mice. Retinas of the 44TNJ mouse were also very heavily stained by the anti-GFAP antibody.
Three other pedigrees (i.e., 73TND, 115TND and 117TNP) shared a common characteristic of having a normal histologic appearance of the retina, yet immunohistochemical analyses revealed an aberrantly light calbindin-positive staining of horizontal cells of the outer retina and a subtype of amacrine cells in the inner retina. This feature, although common in the Purkinje cells of the aged cerebellum, is not shared by the retinas of all aged mice. The 117TNP pedigree was also called as a mutant in 10-week-old mice for aberrant pigmentation patterns of the fundus. In the young mice, the calbindin positive staining patterns were normal, thus this feature appears to be age-related.
The final aberrant ocular phenotype of the aged mice occurred in the 163TNP pedigree. In this mouse, a ring-like pattern of subretinal depigmentation was present in the fundus examination. Retinal histology and immunohistochemical findings were normal in this pedigree, although there appeared to be some Like the 44TNJ and 117TNP pedigrees, this line was called as a mutant pedigree in 10-week-old mice. The aberrant nature of this pedigree appeared to progress to include depigmentation of the fundus to the area surrounding the optic nerve head, a feature that was not present in the younger mutant mice. Potential ocular abnormalities are summarized in Table 3 .
Potential mutants in the extra-aging colony
To date, 202 pedigrees have gone into extra aging beyond 18 months, and more are being added daily. Sixty pedigrees with six mice remaining have been screened for growth/stress indicators, and Table 4 shows potential mutants; all of these are in the process of recovery of young mice for re-aging, some by mating the aged males, and some by ICSI. Figures 2Y5 give examples of data analysis and presentation of representative potential mutants from Table 2 . Inspection of the SAS plots in Figures 2Y5 gives an idea of the degree of variance we experience for the growth/stress tests; this variance is limited enough that we can call statistical outliers as potential mutants for retest. Since we have not yet re-aged any of the potentially mutant pedigrees for retest, we cannot yet calculate our success rate in confirming mutants on these tests.
Recovery via the breeding of aged males, or by intracytoplasmic sperm injection (ISCI) using cryopreserved sperm.
Homozygous cutants from pedigrees 12TNJ (learning/memory), 23TND (hearing), 66TNP (acoustic startle response), and 122TNP (low body weight) are maintained live. Live heterozygotes for three cutant aging lines, 92TNC (cold challenge and IGF-1), 138TNA (IGF-1 and insulin), and 166TNC (low body weight and leptin) have been recovered via intracytoplasmic sperm injection into mouse oocytes using frozen sperm. For the remaining potential mutants, aged males are in matings at this time; ICSI will be used to recover lines for which the current matings are unsuccessful.
Discussion
The potential mutants illustrated in Tables 2Y4 and  Figures 2Y5, although not yet proven heritable, represent single-gene mutations with pronounced effects on complex whole-organism phenotypes critical to normal CNS function, to homeostasis and maybe to longevity. From neurohistology screening, we are identifying a set of neuroanatomical changes that are associated with the aged brain in addition to our potential for discovering abnormal phenotypes resulting from induced new recessive mutations. We see decreased numbers of proliferating cells in the rostral migratory stream and dentate gyrus as seen with antiBrdU immunocytochemistry, and reduced numbers of anti-histone H3 positive cells in these areas. There also is an increase in ectopically placed histone H3-positive cells in regions that are not identified as normally proliferative including the striatum and various areas of cortex. An increase in GFAP immunoreactivity is also a hallmark of the aged brain, and this is particularly obvious in the thalamus. Finally, there is a variable but obvious drop out of Calbindin-positive Purkinje cells in the aged cerebellum. We are refining a set of quantitative measures of finer brain structure (cerebellar perimeter and area, cortical length and thickness, and area of the corpus callosum) that will provide a more in depth and quantitative view on brain structure. Our screening further targets ocular structure and function. The first steps of vision comprise a multistep process involving a complex network of retinal neurons along with the supportive ocular structures that nourish and protect the retina. Multiple genetic mutations may have a late onset and therefore will not affect the quality of vision until the later stages of life. Other mutations have an early onset followed by progressive degeneration that may lead to loss of vision. In our analyses of aged mice, we have identified several pedigrees that may have a late onset occurrence of a disruption in Calbindin-positive cells. Although we have not tested the visual function of these mice, this immunohistochemical finding may indicate a disrupted ability of these pedigrees to process the visual stimuli presented to the eye. We have also identified several mutant pedigrees that appear to have progressive phenotypes that include an apparent loss of photoreceptor cells, loss of cell-specific marker proteins and loss of subretinal pigmentation that Figure 2 . Body temperature of 92TNC after 120 min at 4 -C. Note also 253TNB, with temperature now down to normal at 120 min following consistent hyperthermia at earlier time points. SAS plot of data from cold challenge after 120 min at 4 -C from distal chromosome 15 families TNA, TNB, and TNC. Pedigrees are listed across the bottom, with data points from individual animals of the pedigree arranged vertically above each pedigree. The solid line at mid-plot is the mean of all aged pedigrees tested from the Chr 15 families, and the dotted lines represent two standard deviations from the mean. Arrows indicate outliers; all four homozygous mice tested from 92TNC were unable to maintain body temperature at 4 -C. In the case of 253 TNB, all three aged mice were hyperthermic throughout the test (0, 30, 60, and 90 min), with temperatures finally coming down to normal after 120 min in the cold. Note that 253 TNB also has low brain weight in aged animals, although n = only 2 thus far.
were not evident at 10 weeks of age. It must be stressed that the putant pedigrees for an ocular phenotype must be confirmed in additional mice prior to flagging of any pedigree for a mutant phenotype associated with aging.
Our statistical aim for this project is to identify, from among the majority of pedigrees that will be normal for these phenotypes amenable to highthroughput screening, the few pedigrees that may be abnormal due to a new ENU mutation. In all cases of the discovery (as opposed to the confirmation) phase of this screening, we compare the performance of four test-class mice from each pedigree with the performance of the test-class cohorts from all other pedigrees from that experiment ( Table 1 outlines the experimental groups). There are, in the discovery phase, no formal controls other than the other pedigrees in the population, and no data are obtained from parental or grandparental mice. In the confirmation phase, which will come later for these potentially mutant aging pedigrees, statistically adequate numbers of mice from all possible genotypes will be tested to confirm both heritability and segregation patterns of each abnormal phenotype.
The goal of the statistical analysis of data from these primary screening tests, most of which are designed to identify abnormal phenotypes in apparently normal mice, is to identify pedigrees that are statistical outliers based on comparison to their particular test-class population. The age-onset behavioral, ocular, neuroanatomical, and longevity-associated phenotypes being assayed all likely behave as complex traits with inherent statistical variance resident in the tests. Inspection of the SAS plots in Figures 2Y5 give an idea of the degree of variance we experience for the growth/stress tests; this variance is limited enough that we can call statistical outliers as potential mutants for retest. Since we have not yet reaged any of the potentially mutant pedigrees for retest, we cannot yet calculate our success rate in confirming mutants on these tests. Our experience in testing in young mice (about eight weeks old) from these same pedigrees on all of the behavior tests being used for the agers has taught us that when we have tested 20 or more test-class mice from two or more generations, we have been safe in designating the new phenotype as Bmutant^and Bheritable.^Only retest of at least 20 aged mice from the next generation will tell us if these new age-onset phenotypes meet the Bmutant^and Bheritable^criteria.
Phenotype reliability, that is, the likelihood that phenotypes declared as potentially mutant will turn out to be heritable and to persist as detectable abnormalities in future generations, can be estimated using a new statistical tool in Mutrack at http:// www2.tnmouse.org/mutrack/stats/heritability/php. This tool estimates our ability to detect the heritability of a particular phenotype, and is particularly useful if standard inbred strains have been phenotyped using a test with inherent variability. The tool is, however, also useful for assessing screening, like ours, in which only experimental animals have been tested. If one applies this tool to, for example, body weight taken for mice at 19 months of age, the heritability is 0.7 (SE 0.08), and we would expect an abnormal body-weight phenotype at this age to prove heritable as this is a complex trait. The acid test of phenotype reliability will occur, of course, only when these potential mutations have been confirmed experimentally.
High-throughput and robust screening protocols have been developed and validated for identifying age-onset disturbances of neurological function, and for growth and stress parameters that may predict longevity. Mice 28 months and older are available for additional or new screening assays that could be performed here in our colony. Thirteen potential mutants are or will be available to interested researchers. Each of these 13 has been or is being recovered as young animals for further testing and re-aging to confirm the stability and heritability of the new mutant phenotype. Our screening targets for the extra-aged (to 28 months) mice are new mutations in genes responsible for growth and for stress resistance, since mutations in invertebrates and now in mice in growth and stress genes have been shown to be Blongevity genes^(e.g., Holzenberger et al. 2003; Napoli et al. 2003 , Migliaciccio et al. 1999 . Several potential mutants are outliers in more than one screen; 92TNC, for example, shows an inability to maintain core temperature upon cold challenge, and also has higher than normal levels of IGF-1. 253TNB tends toward low brain weight in aged animals, and is also hyperthermic (Figure 2 ). 122TNP, with low body weight evidenced during aging (Figure 5 ), is also an outlier for nociception in young mice as determined by latency to lift paws from a 52 -C hot plate (data not shown). 138TNA shows increased levels of both insulin (Figure 4 ) and IGF-1 (Figure 3) .
Because we are just beginning to understand the relationships between longevity, growth, and stress resistance, it is imperative that we identify the collection of genes and gene networks, likely preserved in evolution from yeast to humans, that mediate life span. Although we can use a genebased, targeted approach to identifying and characterizing that set of genes it is imperative that we continue our search, via phenotype screening, for those novel genes whose role in longevity has not been realized or does not exist in lower eukaryotes. Once the genes responsible for these newly induced single-gene mutations have been mapped and cloned, we may discover new individual players in the longevity game and through them, identify the full set of cellular processes that govern life span.
